Search Results 1691-1700 of 21496 for platelets

  1. Positron emission tomography scan - Mayo Clinic

    Learn how this imaging scan can play an important role in early detection of health problems, such as cancer, heart disease and brain disorders.

  2. Exenatide (subcutaneous route) - Mayo Clinic

    This medicine may lower the number of platelets in your blood, causing your body to not form blood clots. ... Your blood platelet count may continue to be ...

  3. A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection - Mayo Clinic

    Platelet count ≥ 100,000 plts/mm3 (without transfusion); ≥ 75,000 plts/mm3 for patients with hepatocellular carcinoma only. For hematologic malignancy ...

  4. Lenalidomide and Low-Dose Dexamethasone in Patients with Previously Treated Multiple Myeloma and Kidney Dysfunction - Mayo Clinic

    Platelet count ≥75,000/mm³; Total bilirubin ≤2 mg/dL; AST and ALT ≤3 x upper limit of normal. Renal impairment at baseline as measured by serum creatinine ...

  5. Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps - Mayo Clinic

    Platelets >= 100 B/L (10^9/L); White blood cell (WBC) > 2.5 B/L (10^9/L); Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT]) ...

  6. A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma

    Platelets ≥ 100,000 mm^3;; Total bilirubin ≤ 1.5 x ULN (upper limit of normal);; Aspartate Aminotransferase (AST) ≤ 2.5 x ULN;; Serum Glutamic-Oxaloacetic ...

  7. Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL) - Mayo Clinic

    Have a platelet count >75,000/mm3; Have total bilirubin <2.0 mg/dL; Have aspartate aminotransferase and alanine aminotransferase <3 times the upper limit of ...

  8. A Phase 1 Study Evaluating the Safety, PK, and Clinical Effects of PT-112 in Subjects With Advanced Solid Tumors

    Platelets ≥ 100 x 10^9 /L (100,000/µL);; Hb > 9 g/dL without transfusion or EPO dependency (within 7 days of assessment);; ALT and AST ≤ 2.5 x upper limit ...

  9. Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma - Mayo Clinic

    Hematology: Absolute neutrophil count (ANC) >1,500 cells/mm3, platelet count >100,000 cells/ mm.cu. and hemoglobin > 9 g/dL;; Hepatic: bilirubin <1.5 X Upper ...

  10. A Study Combining Tofacitinib with Gemcitabine for the Treatment of Pancreas Cancer in Patients who are Losing Weight - Mayo Clinic

    Platelet ≥ 100,000/ mm3; Total bilirubin ≤ 2 x upper limit of normal (ULN); AST (SGOT) ≤ 3 x ULN; Creatinine ≤ 1.5 x ULN; Hemoglobin ≥ 9.0 g/dL; Cohort II ...